WebBackground and purpose: In patients with head-and-neck cancer treated with chemoradiotherapy (CRT), a cisplatin-based regimen is often used. Several treatment schedules are accepted with a cumulative cisplatin dose of 200 mg/m (2) (CisCD200) given during radiotherapy. WebSep 21, 2016 · RTOG 88-08 used a chemoradiotherapy regimen of cisplatin 100 mg/m 2 on days 1 and 29 and vinblastine 5 mg/m 2 once per week for 5 consecutive weeks beginning on day 1, followed by TRT to a total dose of 60 Gy in …
Cisplatin + RT for Triple Negative Breast Cancer
WebFeb 16, 2016 · Cisplatin is standardly dosed in a three-weekly schedule of 100 mg/m 2 (total dose 300 mg/m 2) combined with standard RT [3,6,7,9,10]. However, a high-dose cisplatin regimen is associated with major toxic side effects (myelosuppression, neurotoxicity, ototoxicity, and nephrotoxicity). WebWeekly cisplatin with radiotherapy for locally advanced head and neck squamous cell carcinoma Our study shows that a median cumulative dose of 200 mg/m2 cisplatin can be safely administered using a weekly regimen to patients treated with concomitant RT (CFRT or ART). phop ptown
High-Dose Cisplatin for Head and Neck Cancer Lives On
WebMar 1, 2024 · In the weekly arm, cisplatin was administered at 40 mg/m 2 once a week for seven cycles during the RT period. Criteria for dose reduction or delay were … Web1 day ago · Combined treatment with idronoxil and cisplatin enhances tumor response in humanized mice model. ... (Qiagen) according to the manufacturer's instructions. Total RNA (500 ng) was reversed transcribed with Primescript RT (Takara), with the cDNA serving as the template for amplification. Quantitative real-time PCR was subsequently performed … WebSep 21, 2016 · Cisplatin was discontinued for grade 3 or 4 peripheral neuropathy. During those weeks in which the patient did not receive CT, RT was continued as long as the WBC count was ≥ 2000/μL and the platelet count was ≥ 50,000/μL. RT was interrupted for a period of no greater than 1 week for grade 3 or 4 diarrhea. phophaketene stretching frequency